Effects of glucocorticoids and of growth hormone on serum leptin concentrations in man

Department of Internal Medicine, University Hospital Basel, Switzerland.

Recent data suggest an involvement of the ob gene and its product leptin in the regulation of body fat. To assess the effects of glucocorticoids and growth hormone (GH) on serum leptin and body fat, 30 normal subjects received methylprednisolone (0.5 mg.kg-1.day-1) per os for 7 days and 15 subjects received in addition sc injections of GH (0.15 IU.kg-1.day-1) twice daily (combination group). Serum leptin levels increased both in the glucocorticoid group (p < 0.02) and in the combination group (p < 0.002). When body fat was estimated by bioelectrical impedance analysis it decreased during combined treatment and remained unchanged in the glucocorticoid group. Plasma insulin concentrations increased in both groups. Resting energy expenditure (indirect calorimetry) increased in the combination group and remained unchanged in the glucocorticoid group. The finding of increased serum leptin concentrations during treatment with glucocorticoid and GH suggests that serum leptin is regulated by glucocorticoids, possibly though changes in insulin secretion, independently of changes of body fat mass.

This article has been cited by other articles:

				R. R. Kraemer, H. Chu, and V. D. Castracane Leptin and Exercise Experimental Biology and Medicine, October 1, 2002; 227(9): 701 - 708. [Abstract] [Full Text] [PDF]

				H. A. Weiler, H. Kovacs, C. Murdock, J. Adolphe, and S. Fitzpatrick-Wong Leptin Predicts Bone and Fat Mass after Accounting for the Effects of Diet and Glucocorticoid Treatment in Piglets Experimental Biology and Medicine, September 1, 2002; 227(8): 639 - 644. [Abstract] [Full Text] [PDF]

				S. S. Damjanovic, M. S. Petakov, D. Micic, J. Marinkovic, C. Dieguez, F. F. Casanueva, and V. Popovic Serum Leptin Levels in Patients with Acromegaly before and after Correction of Hypersomatotropism by Trans-Sphenoidal Surgery J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 147 - 154. [Abstract] [Full Text]

				M. Weise, V. Abad, R. V. Considine, L. Nieman, and K. I. Rother Leptin Secretion in Cushing's Syndrome: Preservation of Diurnal Rhythm and Absent Response to Corticotropin-Releasing Hormone J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2075 - 2079. [Abstract] [Full Text]

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				J. W. Newcomer, G. Selke, A. K. Melson, J. Gross, G. P. Vogler, and S. Dagogo-Jack Dose-Dependent Cortisol-Induced Increases in Plasma Leptin Concentration in Healthy Humans Arch Gen Psychiatry, November 1, 1998; 55(11): 995 - 1000. [Abstract] [Full Text] [PDF]

				M. Miyakawa, T. Tsushima, H. Murakami, O. Isozaki, H. Demura, and T. Tanaka Effect of Growth Hormone (GH) on Serum Concentrations of Leptin: Study in Patients with Acromegaly and GH Deficiency J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3476 - 3479. [Abstract] [Full Text]

				G. Van den Berghe, P. Wouters, L. Carlsson, R. C. Baxter, R. Bouillon, and C. Y. Bowers Leptin Levels in Protracted Critical Illness: Effects of Growth Hormone-Secretagogues and Thyrotropin-Releasing Hormone J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3062 - 3070. [Abstract] [Full Text]

				E. D. Eckert, C. Pomeroy, N. Raymond, P. F. Kohler, P. Thuras, and C. Y. Bowers Leptin in Anorexia Nervosa J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 791 - 795. [Abstract] [Full Text]

				M. F. Saad, M. G. Riad-Gabriel, A. Khan, A. Sharma, R. Michael, S. D. Jinagouda, R. Boyadjian, and G. M. Steil Diurnal and Ultradian Rhythmicity of Plasma Leptin: Effects of Gender and Adiposity J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 453 - 459. [Abstract] [Full Text]